Ignite Creation Date:
2024-10-25 @ 8:04 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06504472
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-11
Brief Title:
A Randomized Triple-Blind Placebo-Controlled Study to Evaluate the Effects of a Supplement on Lower Urinary Tract Symptoms in Men
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Randomized Triple-Blind Placebo-Controlled Study to Evaluate the Effects of a Supplement on Lower Urinary Tract Symptoms in Men
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to evaluate the effects of the ProstaThrive supplement on lower urinary tract symptoms LUTS in men It is a 90-day virtual randomized placebo-controlled trial with 80 male participants aged 40 and above The primary endpoint is the reduction in LUTS while secondary endpoints include changes in sexual function and performance
Detailed Description:
This is a virtual two-arm randomized placebo-controlled clinical trial lasting 90 days Participants will take the ProstaThrive supplement or a placebo daily and complete questionnaires at Baseline Day 30 Day 60 and Day 90 The study will assess the efficacy of ProstaThrive on LUTS such as urinary urgency nighttime urination frequency perceived urinary flow and bladder emptying as well as secondary outcomes related to sexual function
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None